MetaCap

PepGen Inc. Company Profile

NASDAQ: PEPGHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.78-0.15 (-3.82%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

PepGen at a glance

PepGen Inc. (NASDAQ: PEPG) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Boston, MA. PepGen is led by Dr. James G. McArthur Ph.D. and employs about 53 people. The company's shares have traded publicly since 2022.

At a market capitalization of $356.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001835597, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does PepGen do?

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.

Business description based on the company's public filings.

Company information

Legal name
PepGen Inc.
Ticker
NASDAQ: PEPG
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. James G. McArthur Ph.D.
Employees
53
Headquarters
321 Harrison Avenue, Boston, MA, United States
Phone
781 797 0979
Website
pepgen.com
IPO year
2022
Market cap
$356.31M
SEC CIK
0001835597
Latest annual report
10-K · Mar 4, 2026

Companies similar to PepGen

PEPG peer companies
CompanyPrice% ChgMarket capCompare
ASPEAspen Neuroscience Inc.12.42+0.24%$361.16Mvs PEPG
PBYIPuma Biotechnology Inc7.05-0.98%$364.47Mvs PEPG
CTNMContineum Therapeutics Inc. Class A8.68-3.98%$340.83Mvs PEPG
PHATPhathom Pharmaceuticals Inc.4.66-8.27%$378.82Mvs PEPG
MPLTMapLight Therapeutics Inc.5.94-7.48%$330.12Mvs PEPG
INOInovio Pharmaceuticals Inc.1.76+2.92%$329.66Mvs PEPG
LRMRLarimar Therapeutics Inc.3.14-2.48%$328.55Mvs PEPG
IRDOpus Genetics Inc.3.99-2.21%$385.65Mvs PEPG

Related